Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,775 GBX | 0.00% | -1.93% | +22.40% |
06:33am | GSK Faces Whistleblower Lawsuit for Allegedly Hiding Antacid Zantac's Cancer Risks | MT |
05-20 | GSK faces whistleblower lawsuit over Zantac cancer risk | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.40% | 91.96B | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- IDEAYA Biosciences Says US FDA Cleared Investigational New Drug Application for GSK-Sponsored Solid Tumor Therapy Trial